INSP in “GLP-1 Eats Everything”
Inspire Medical Systems, Inc.
Weight loss can improve obstructive sleep apnea severity, potentially reducing the number of patients who ultimately need Inspire's implanted neurostimulation system.
INSP impact map — “GLP-1 Eats Everything”
How this story travels from the headline to INSP’s own business — positive, negative or mixed, direct or indirect, the mechanism, and how strong the exposure is.
Loading INSP impact map…
Price history, marked with story events
Jul 2, 2026 – Oct 2, 2026 · 43 sessions
Prices updated during market hours · refreshed about every 30 minutes while the market is open · delayed data, not for trading decisions
Numbered markers tie price moves to earnings, trial or study results, management comments and analyst or demand data. Loading events…
Full story
GLP-1 Eats Everything
Appetite suppression as a macro variable.
BEAR side — Weight loss can improve obstructive sleep apnea severity, potentially reducing the number of patients who ultimately need Inspire's implanted neurostimulation system.
Read the full GLP-1 Eats Everything storyBull side
1 story- Managed Care's Margin Machine Breaks
INSP in “Managed Care's Margin Machine Breaks”
FadingExposure: not rated yetRising utilization, tougher reimbursement and scrutiny of denials are shifting economics from insurers back to care providers.
Reduced authorization friction and greater procedural capacity can accelerate implantation of its sleep-apnea neurostimulation systems.
Bear side
1 story- Viewing
INSP in “GLP-1 Eats Everything”
FadingExposure: not rated yetAppetite suppression as a macro variable.
Weight loss can improve obstructive sleep apnea severity, potentially reducing the number of patients who ultimately need Inspire's implanted neurostimulation system.